Literature DB >> 26907220

Clinical implications of antibiotic impact on gastrointestinal microbiota and Clostridium difficile infection.

Sahil Khanna1, Darrell S Pardi1.   

Abstract

The human gastrointestinal (GI) microbiota plays an important role in human health. Anaerobic bacteria prevalent in the normal colon suppress the growth of non-commensal microorganisms, thus maintaining colonic homeostasis. The GI microbiota is influenced by both patient-specific and environmental factors, particularly antibiotics. Antibiotics can alter the native GI microbiota composition, leading to decreased colonization resistance and opportunistic proliferation of non-native organisms. A common and potentially serious antibiotic-induced sequela associated with GI microbiota imbalance is Clostridium difficile infection (CDI), which may become recurrent if dysbiosis persists. This review focuses on the association between antibiotics and CDI, and the antibiotic-induced disruption leading to recurrent CDI. Promoting antibiotic stewardship is pivotal in protecting native microbiota and reducing the incidence of CDI and other GI infections.

Entities:  

Keywords:  associated diarrhea; infection; antibiotic-associated diarrhea; antibiotics; microbiome; microbiota; stewardship

Year:  2016        PMID: 26907220     DOI: 10.1586/17474124.2016.1158097

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  17 in total

1.  Characterization of Gastric Microbiota in Twins.

Authors:  Quanjiang Dong; Yongning Xin; Lili Wang; Xinying Meng; Xinjuan Yu; Linlin Lu; Shiying Xuan
Journal:  Curr Microbiol       Date:  2016-12-12       Impact factor: 2.188

2.  Impact of Oral Fidaxomicin Administration on the Intestinal Microbiota and Susceptibility to Clostridium difficile Colonization in Mice.

Authors:  N J Ajami; J L Cope; M C Wong; J F Petrosino; L Chesnel
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

Review 3.  Clinical Practice and Infrastructure Review of Fecal Microbiota Transplantation for Clostridium difficile Infection.

Authors:  Brendan J Kelly; Pablo Tebas
Journal:  Chest       Date:  2017-09-18       Impact factor: 9.410

4.  Impact of Antibiotic Gut Exposure on the Temporal Changes in Microbiome Diversity.

Authors:  Charles Burdet; Thu Thuy Nguyen; Xavier Duval; Stéphanie Ferreira; Antoine Andremont; Jérémie Guedj; France Mentré
Journal:  Antimicrob Agents Chemother       Date:  2019-09-23       Impact factor: 5.191

Review 5.  Factors Influencing Skin Aging and the Important Role of Estrogens and Selective Estrogen Receptor Modulators (SERMs).

Authors:  Edwin D Lephart; Frederick Naftolin
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-08-19

Review 6.  Estrogen Action and Gut Microbiome Metabolism in Dermal Health.

Authors:  Edwin D Lephart; Frederick Naftolin
Journal:  Dermatol Ther (Heidelb)       Date:  2022-06-25

Review 7.  The interplay of Clostridioides difficile infection and inflammatory bowel disease.

Authors:  Kanika Sehgal; Devvrat Yadav; Sahil Khanna
Journal:  Therap Adv Gastroenterol       Date:  2021-05-30       Impact factor: 4.409

8.  Blueberry Phenolics Reduce Gastrointestinal Infection of Patients with Cerebral Venous Thrombosis by Improving Depressant-Induced Autoimmune Disorder via miR-155-Mediated Brain-Derived Neurotrophic Factor.

Authors:  Ning Xu; Hao Meng; Tianyi Liu; Yingli Feng; Yuan Qi; Donghuan Zhang; Honglei Wang
Journal:  Front Pharmacol       Date:  2017-11-27       Impact factor: 5.810

9.  Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel disease.

Authors:  Sahil Khanna; Yoshiki Vazquez-Baeza; Antonio González; Sophie Weiss; Bradley Schmidt; David A Muñiz-Pedrogo; John F Rainey; Patricia Kammer; Heidi Nelson; Michael Sadowsky; Alexander Khoruts; Stefan L Farrugia; Rob Knight; Darrell S Pardi; Purna C Kashyap
Journal:  Microbiome       Date:  2017-05-15       Impact factor: 14.650

Review 10.  Immunoglobulin Y for Potential Diagnostic and Therapeutic Applications in Infectious Diseases.

Authors:  Lucia Lee; Kate Samardzic; Michael Wallach; Lyn R Frumkin; Daria Mochly-Rosen
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.